Invention Grant
- Patent Title: Neutralizing anti-SARS-CoV-2 antibodies
-
Application No.: US17519173Application Date: 2021-11-04
-
Publication No.: US11919945B2Publication Date: 2024-03-05
- Inventor: Michel Nussenzweig
- Applicant: The Rockefeller University
- Applicant Address: US NY New York
- Assignee: The Rockefeller University
- Current Assignee: The Rockefeller University
- Current Assignee Address: US NY New York
- Agency: Fox Rothschild LLP
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61P31/14 ; A61K39/42 ; G01N33/569 ; A61K39/00
Abstract:
This disclosure provides novel broadly neutralizing anti-SARS-CoV-2 antibodies or antigen-binding fragments thereof. The disclosed anti-SARS-CoV-2 antibodies constitute a novel therapeutic strategy in protection against SARS-CoV-2 infections.
Public/Granted literature
- US20220195015A1 NEUTRALIZING ANTI- SARS-COV-2 ANTIBODIES Public/Granted day:2022-06-23
Information query
